Cited by 335Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo: Molecular Size as a Determinant of Fractional Loss From the Intima–Inner Media

Open access

Nordestgaard, Børge G., Wootton, Richard, Lewis, Barry·1995·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/01.atv.15.4.534

Open this paper in CoChat — free account Open PDF

Abstract

Abstract To explore possible mechanisms whereby the triglyceride-rich lipoproteins IDL and VLDL may promote atherosclerosis, fractional loss of these lipoproteins from the intima–inner media was measured in vivo in genetically hyperlipidemic rabbits of the St Thomas’s Hospital strain and compared with the fractional loss of LDL, HDL, and albumin. These rabbits exhibit elevated plasma levels of VLDL, IDL, and LDL. In each rabbit, two aliquots of the same macromolecule, one iodinated with 125 I and the other with 131 I, respectively, were injected intravenously on average 24 and 3 hours, respectively, before removal of the aortic intima–inner media. The fractional loss from the intima–inner media of newly entered macromolecules was then calculated. The average fractional losses for VLDL, IDL, LDL, HDL, and albumin in lesioned aortic arches were 0.1%/h (n=4), −0.2%/h (n=3), 1.8%/h (n=4), 11.4%/h (n=3), and 26.3%/h (n=1), respectively; in nonlesioned aortic arches fractional losses for IDL, LDL, HDL, and albumin were 1.7%/h (n=1), 0.6%/h (n=2), 14.6%/h (n=3), and 25.9%/h (n=3). In both lesioned and nonlesioned aortic arches, the logarithms of these fractional loss values were inversely and linearly dependent on the diameter of the macromolecules (R2=.57,P=.001 and R2=.84,P<.001), as determined from electron photomicrographs of negatively stained lipoproteins. These results suggest that after uptake into the arterial intima, VLDL and IDL as well as LDL are selectively retained in comparison with HDL and albumin.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.atv.15.4.534

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
Beyond Cholesterol
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Mammalian Protein Metabolism
(1964) · Elsevier eBooks · doi:10.1016/b978-1-4832-3210-2.50006-6 · Cited by 3,130
Efficient Trace-labelling of Proteins with Iodine
McFarlane, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,559
The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations
Bilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,815
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
Manninen, V, Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.37 · Cited by 1,329
Plasma triglyceride and coronary heart disease
Austin, M. A. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.2 · Cited by 697
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study
Manninen, V., Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Op, H., & Frick, H. M. (1992) · Circulation · Cited by 360
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.
Blankenhorn, D. H., Alaupovic, P., Wickham, E., Chin, H. P., & Azen, S. P. (1990) · Circulation · doi:10.1161/01.cir.81.2.470 · Cited by 278

Show all 49 references

Research works printed but not linked: 14

10.1161/circ.83.6.2040066 · DOI
10.1161/circ.60.3.222498 · DOI
10.1161/circ.64.6.7296792 · DOI
10.1161/circ.71.5.3986978 · DOI
10.1161/circ.75.1.3791598 · DOI
10.1161/atv91.12.1.1731859 · DOI
10.1161/atv91.11.3.2029497 · DOI
Ryan BF Joiner BL Ryan TA Jr. MINITAB Handbook . 2nd ed. Boston Mass: Duxbury Press; 1985:218-259.
10.1161/atv91.13.9.8364021 · DOI
1982, J Biol Chem, 260, 8783
1987, Arteriosclerosis, 7, 203
10.1161/circ.81.2.2404631 · DOI
10.1161/atv91.11.1.1987999 · DOI
10.1161/circ.85.1.1728471 · DOI

Sorted by citations

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citation
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citation
Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419
Self-citation
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116
Self-citation
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115
Self-citation
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
Self-citation
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919
Self-citation
Atherosclerosis and inflammation: overview and updates
Geovanini, G. R., & Libby, P. (2018) · Clinical Science · doi:10.1042/cs20180306 · Cited by 711
Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation
Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Circulation · doi:10.1161/circulationaha.113.003008 · Cited by 692
Self-citation
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Hegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70191-8 · Cited by 635
Self-citation
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
Deprince, A., Haas, J. T., & Staels, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101092 · Cited by 576
Nonfasting triglycerides and risk of ischemic stroke in the general population
Freiberg, J. J. (2008) · JAMA · doi:10.1001/jama.2008.621 · Cited by 542
Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
Jørgensen, A. B., Frikke-Schmidt, R., West, A. S., Grande, P., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs431 · Cited by 501
Self-citation
Association of Loss-of-Function Mutations in the <emph type="ital">ABCA1</emph> Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
Frikke-Schmidt, R. (2008) · JAMA · doi:10.1001/jama.299.21.2524 · Cited by 464
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: A primary prevention study
Quispe, R., Martin, S. S., Michos, E. D., Lamba, I., Blumenthal, R. S., Saeed, A., Lima, J., Puri, R., Nomura, S., Tsai, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab432 · Cited by 441
Effects of aerobic exercise on lipids and lipoproteins
Wang, Y., & Xu, D. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0515-5 · Cited by 436
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease: A Meta-Analysis
Wittrup, H. H., Tybjærg-Hansen, A., & Nordestgaard, B. G. (1999) · Circulation · doi:10.1161/01.cir.99.22.2901 · Cited by 344
Self-citation
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease
Duran, E. K., Aday, A. W., Cook, N. R., Buring, J. E., Ridker, P. M., & Pradhan, A. D. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.059 · Cited by 347
Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
Contois, J. H., McConnell, J. P., Sethi, A. A., Csako, G., Devaraj, S., Hoefner, D. M., & Warnick, G. R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118356 · Cited by 326
Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement
D. Kolovou, G., P. Mikhailidis, D., Kovar, J., Lairon, D., G. Nordestgaard, B., Chye Ooi, T., Perez-Martinez, P., Bilianou, H., Anagnostopoulou, K., & Panotopoulos, G. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111795495549 · Cited by 306
Self-citation
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262
Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment
Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251
Self-citation
Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
Toth, P. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s104369 · Cited by 237
Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study
Wadström, B. N., Wulff, A. B., Pedersen, K. M., Jensen, G. B., & Nordestgaard, B. G. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab705 · Cited by 234
Self-citation
Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up
Langsted, A., Freiberg, J., Tybjærg‐Hansen, A., Schnohr, P., Jensen, G. B., & Nordestgaard, B. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02333.x · Cited by 234
Self-citation
A Test in Context: Lipid Profile, Fasting Versus Nonfasting
Nordestgaard, B. G. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.006 · Cited by 223
Self-citation
Increased remnant cholesterol explains part of residual risk of all-cause mortality in 5414 patients with ischemic heart disease
Jepsen, A.-M. K., Langsted, A., Varbo, A., Bang, L. E., Kamstrup, P. R., & Nordestgaard, B. G. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.253757 · Cited by 218
Self-citation
Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population
Varbo, A., Freiberg, J. J., & Nordestgaard, B. G. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.234146 · Cited by 209
Self-citation
T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor
Zakharova, L., Svetlova, M., & Fomina, A. F. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21013 · Cited by 215
Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis
Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00001 · Cited by 200
Association of rare and common variation in the lipoprotein lipase gene with coronary artery disease
Khera, A. V., Won, H.-H., Peloso, G. M., O’Dushlaine, C., Liu, D., Stitziel, N. O., Natarajan, P., Nomura, A., Emdin, C. A., Gupta, N., et al. (2017) · JAMA · doi:10.1001/jama.2017.0972 · Cited by 198
Echo-Lucency of Computerized Ultrasound Images of Carotid Atherosclerotic Plaques Are Associated With Increased Levels of Triglyceride-Rich Lipoproteins as Well as Increased Plaque Lipid Content
Grønholdt, M.-L. M., Nordestgaard, B. G., Wiebe, B. M., Wilhjelm, J. E., & Sillesen, H. H. (1998) · Circulation · doi:10.1161/01.cir.97.1.34 · Cited by 188
Self-citation
Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis
Nielsen, L. B. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05802-9 · Cited by 186
Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.
Shoji, T., Nishizawa, Y., Kawagishi, T., Kawasaki, K., Taniwaki, H., Tabata, T., Inoue, T., & Morii, H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v971277 · Cited by 183
Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives
Chapman, M. J. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00156-4 · Cited by 181
VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins
Balling, M., Afzal, S., Varbo, A., Langsted, A., Davey Smith, G., & Nordestgaard, B. G. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.610 · Cited by 175
Self-citation
Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction
Varbo, A., & Nordestgaard, B. G. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab293 · Cited by 178
Self-citation
Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study
Thomsen, M., Varbo, A., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.219881 · Cited by 171
Self-citation
Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Blood Pressure as Mediators From Obesity to Ischemic Heart Disease
Varbo, A., Benn, M., Smith, G. D., Timpson, N. J., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2014) · Circulation Research · doi:10.1161/circresaha.116.304846 · Cited by 171
Self-citation
The atherogenic lipoprotein phenotype and vascular endothelial dysfunction
Sattar, N. A., Petrie, J. R., & Jaap, A. J. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00037-9 · Cited by 162
Acid Sphingomyelinase Promotes Lipoprotein Retention Within Early Atheromata and Accelerates Lesion Progression
Devlin, C. M., Leventhal, A. R., Kuriakose, G., Schuchman, E. H., Williams, K. J., & Tabas, I. A. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.173344 · Cited by 160
Postprandial lipemia and cardiovascular disease
Hyson, D. A., Rutledge, J. C., & Berglund, L. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0033-y · Cited by 160
Serum triglycerides and risk of cardiovascular disease
Boullart, A. C. I., Graaf, J. D., & Stalenhoef, A. F. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.002 · Cited by 159
Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins
Cohn, J. S., Marcoux, C., & Davignon, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2474 · Cited by 156
Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis
Morita, S. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00716 · Cited by 161
Intermediate-Density Lipoproteins and Progression of Carotid Arterial Wall Intima-Media Thickness
Hodis, H. N., Mack, W. J., Dunn, M. E., Liu, C., Ci-hua, L., Selzer, R. H., & Krauss, R. M. (1997) · Circulation · doi:10.1161/01.cir.95.8.2022 · Cited by 155
Immunobiology of Atherosclerosis: A Complex Net of Interactions
Herrero‐Fernández, B., Gómez-Bris, R., Somovilla-Crespo, B., & González, J. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215293 · Cited by 158
Triglycerides as vascular risk factors: new epidemiologic insights.
Kannel, W. B., & Vasan, R. S. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832c1284 · Cited by 149
Heterozygous Lipoprotein Lipase Deficiency: Frequency in the General Population, Effect on Plasma Lipid Levels, and Risk of Ischemic Heart Disease
Nordestgaard, B. G., Abildgaard, S., Wittrup, H. H., Steffensen, R., Jensen, G., & Tybjærg-Hansen, A. (1997) · Circulation · doi:10.1161/01.cir.96.6.1737 · Cited by 146
Self-citation
Advances in lipid-lowering therapy through gene-silencing technologies
Nordestgaard, B. G., Nicholls, S. J., Langsted, A., Ray, K. K., & Tybjærg‐Hansen, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2018.3 · Cited by 148
Self-citation
Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population
Varbo, A., & Nordestgaard, B. G. (2019) · Annals of Neurology · doi:10.1002/ana.25432 · Cited by 145
Self-citation
Remnant Cholesterol and Triglyceride-Rich Lipoproteins in Atherosclerosis Progression and Cardiovascular Disease
Varbo, A., & Nordestgaard, B. G. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308305 · Cited by 147
Self-citation
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0864-7 · Cited by 140
Self-citation
NONOXIDATIVE MODIFICATIONS OF LIPOPROTEINS IN ATHEROGENESIS
Tabas, I. A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.123 · Cited by 138
Remnant lipoproteins
Varbo, A., & Nordestgaard, B. G. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000429 · Cited by 135
Self-citation
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease
Schlitt, A., Blankenberg, S., Yan, D., von Gizycki, H., Buerke, M., Werdan, K., Bickel, C., Lackner, K. J., Meyer, J., Rupprecht, H. J., et al. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-5 · Cited by 134
Remnant cholesterol and myocardial infarction in normal weight, overweight, and obese individuals from the copenhagen general population study
Varbo, A., Freiberg, J. J., & Nordestgaard, B. G. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.279463 · Cited by 133
Self-citation
Postprandial lipoproteins and the molecular regulation of vascular homeostasis
Botham, K. M., & Wheeler-Jones, C. P. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.06.001 · Cited by 137
Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis
Schwartz, E. A., & Reaven, P. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.021 · Cited by 130
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment
Chait, A., & Eckel, R. H. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0203 · Cited by 128
Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction
Doi, T., Langsted, A., & Nordestgaard, B. G. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.384 · Cited by 129
Self-citation
Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis
Fogelstrand, P., & Borén, J. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.09.007 · Cited by 127
Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population
Varbo, A., Nordestgaard, B. G., Tybjærg‐Hansen, A., Schnohr, P., Jensen, G. B., & Benn, M. (2011) · Annals of Neurology · doi:10.1002/ana.22384 · Cited by 122
Self-citation
Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
Nordestgaard, L. T., Christoffersen, M., & Frikke‐Schmidt, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179777 · Cited by 128
High Density Lipoprotein-associated Sphingosine 1-Phosphate Promotes Endothelial Barrier Function
Argraves, K. M., Gazzolo, P. J., Groh, E. M., Wilkerson, B. A., Matsuura, B. S., Twal, W. O., Hammad, S. M., & Argraves, W. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801214200 · Cited by 121
Phospholipase A2 Modification of Low Density Lipoproteins Forms Small High Density Particles with Increased Affinity for Proteoglycans and Glycosaminoglycans
Sartipy, P., Camejo, G., Svensson, L., & Hurt‐Camejo, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25913 · Cited by 118
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
Argraves, K. M., Sethi, A. A., Gazzolo, P. J., Wilkerson, B. A., Remaley, A. T., Tybjærg‐Hansen, A., Nordestgaard, B. G., Yeatts, S. D., Nicholas, K. S., Barth, J. L., et al. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-70 · Cited by 117
Self-citation
Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux
Nielsen, L. B. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00064-7 · Cited by 115
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
Wittrup, H. H., Tybjærg‐Hansen, A., Abildgaard, S., Steffensen, R., Schnohr, P., & Nordestgaard, B. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119323 · Cited by 114
Self-citation
Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100
Véniant, M. M., Sullivan, M. A., Kim, S. K., Ambroziak, P., Chu, A., Wilson, M. D., Hellerstein, M. K., Rudel, L. L., Walzem, R. L., & Young, S. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10695 · Cited by 114
Remnant Cholesterol Variability and Incident Ischemic Stroke in the General Population
Li, W., Huang, Z., Fang, W., Wang, X., Cai, Z., Chen, G., Wu, W., Chen, Z., Wu, S., & Chen, Y. (2022) · Stroke · doi:10.1161/strokeaha.121.037756 · Cited by 114
Sequestration of aggregated low-density lipoproteins by macrophages
Kruth, H. S. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00003 · Cited by 111
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease
Duran, E. K., & Pradhan, A. D. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa296 · Cited by 108
Lipoprotein Lipase in the Arterial Wall
Pentikäinen, M. O., Oksjoki, R. K., Öörni, K., & Kovanen, P. T. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101551 · Cited by 108
Is maternal lipid profile in early pregnancy associated with pregnancy complications and blood pressure in pregnancy and long term postpartum?
Adank, M. C., Benschop, L. H., Peterbroers, K. R., Gregoor, A. M. S., Kors, A. W., Mulder, M. T., Schalekamp–Timmermans, S., van Lennep, J. E. R., & Steegers, E. A. P. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.03.025 · Cited by 106
Arterial Permeability and Efflux of Apolipoprotein B–Containing Lipoproteins Assessed by In Situ Perfusion and Three-Dimensional Quantitative Confocal Microscopy
Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000143859.75035.5a · Cited by 103
Grape Seed and Grape Skin Extracts Elicit a Greater Antiplatelet Effect When Used in Combination than When Used Individually in Dogs and Humans
Shanmuganayagam, D., Beahm, M. R., Osman, H. E., Folts, J. D., Krueger, C. G., & Reed, J. D. (2002) · Journal of Nutrition · doi:10.1093/jn/132.12.3592 · Cited by 103
Atherogenic Lipoproteins Support Assembly of the Prothrombinase Complex and Thrombin Generation: Modulation by Oxidation and Vitamin E
Rota, S., McWilliam, N. A., Baglin, T. P., & Byrne, C. D. (1998) · Blood · doi:10.1182/blood.v91.2.508 · Cited by 103
HDL endocytosis and resecretion
Röhrl, C., & Stangl, H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.07.014 · Cited by 101
ATP-Binding Cassette Transporter A1 Modulates Apolipoprotein A-I Transcytosis Through Aortic Endothelial Cells
Cavelier, C., Rohrer, L., & von Eckardstein, A. (2006) · Circulation Research · doi:10.1161/01.res.0000250567.17569.b3 · Cited by 99
Hepatic Lipase, Genetically Elevated High-Density Lipoprotein, and Risk of Ischemic Cardiovascular Disease
Johannsen, T. H., Kamstrup, P. R., Andersen, R. V., Jensen, G. B., Sillesen, H. H., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1342 · Cited by 99
Self-citation
The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes
Cao, Y., Zhang, H., Jin, J., Liu, H., Zhang, Y., Gao, Y., Guo, Y., Wu, N., Hua, Q., Li, Y., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01076-7 · Cited by 100
Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins
von Eckardstein, A., & Rohrer, L. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832afd63 · Cited by 97
Endocytosis of lipoproteins
Zanoni, P., Velagapudi, S., Yalçınkaya, M., Rohrer, L., & von Eckardstein, A. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.881 · Cited by 97
Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population
Frikke-Schmidt, R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.005 · Cited by 94
Sphingomyelinase Induces Aggregation and Fusion of Small Very Low–Density Lipoprotein and Intermediate-Density Lipoprotein Particles and Increases Their Retention to Human Arterial Proteoglycans
Öörni, K., Posio, P., Ala‐Korpela, M., Jauhiainen, M., & Kovanen, P. T. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000168912.42941.60 · Cited by 93
Direct Visualization of Lipid Deposition and Reverse Lipid Transport in a Perfused Artery
Rutledge, J., Mullick, A. E., Gardner, G., & Goldberg, I. J. (2000) · Circulation Research · doi:10.1161/01.res.86.7.768 · Cited by 91
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
Kumari, A., Kristensen, K. K., Ploug, M., & Winther, A.-M. L. (2021) · Biomedicines · doi:10.3390/biomedicines9070782 · Cited by 100
Hyperlipoproteinemia Type 3: The Forgotten Phenotype
Hopkins, P. N., Brinton, E. A., & Nanjee, M. N. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0440-2 · Cited by 91
Novel Insights From Human Studies on the Role of High-Density Lipoprotein in Mortality and Noncardiovascular Disease
Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314050 · Cited by 88
Self-citation
HDL cholesterol and stroke risk: The Multi-Ethnic Study of Atherosclerosis
Reina, S. A., Llabre, M. M., Allison, M., Wilkins, J. T., Mendez, A. J., Arnan, M., Schneiderman, N., Sacco, R. L., Carnethon, M. R., & Delaney, J. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.09.031 · Cited by 87
TRIB1 and GCKR Polymorphisms, Lipid Levels, and Risk of Ischemic Heart Disease in the General Population
Varbo, A., Benn, M., Tybjærg‐Hansen, A., Grande, P., & Nordestgaard, B. G. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.216333 · Cited by 86
Self-citation
Lactobacillus acidophilus CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters
Ooi, L.-G., Ahmad, R., Yuen, K. H., & Liong, M. (2010) · Journal of Dairy Science · doi:10.3168/jds.2010-3311 · Cited by 85
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
Baratta, F., Cocomello, N., Coronati, M., Ferro, D., Pastori, D., Angelico, F., & Ben, M. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054268 · Cited by 89
Lipoprotein-mediated transport of dietary and synthesized lipids and lipid abnormalities of dogs and cats
Bauer, J. E. (2004) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2004.224.668 · Cited by 84
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy
Aguíar, C., Alegría, E., Bonadonna, R. C., Catapano, A. L., Cosentino, F., Elisaf, M., Farnier, M., Ferrières, J., Filardi, P. P., Hâncu, N., et al. (2015) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(15)30001-5 · Cited by 84
Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk: Two Cohort Studies of 113 554 Individuals
Varbo, A., & Nordestgaard, B. G. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.310269 · Cited by 83
Self-citation
Transendothelial transport of lipoproteins
Jang, E., Robert, J., Rohrer, L., von Eckardstein, A., & Lee, W. L. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.09.020 · Cited by 85
Peroxisome proliferator‐activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages
Gbaguidi, F. G., Chinetti, G., Milosavljevic, D., Morier-teissier, E., Chapman, J., Olivecrona, G., Fruchart, J., Griglio, S., Fruchart, J., & Staels, B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02223-8 · Cited by 79

Authors: Nordestgaard, B. G., Wootton, R., & Lewis, B.
Affiliations: University of Copenhagen (DK)
ORCID: Nordestgaard, Børge G.
Wootton, Richard
Lewis, Barry
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1995-04
Volume: 15
Issue: 4
Pages: 534-542
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.15.4.534
OpenAlex: W2150460597
Cited by: 334
References: 49
Citations by year: 2026: 11 · 2025: 17 · 2024: 15 · 2023: 21 · 2022: 18 · 2021: 22 · 2020: 23 · 2019: 14 · 2018: 14 · 2017: 16 · 2016: 8 · 2015: 13 · 2014: 10 · 2013: 6 · 2012: 3
FWCI: 3.44
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: Hjerteforeningen
Sundhed og Sygdom, Det Frie Forskningsråd
Medical Research Council
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: VLDL, IDL, low-density lipoprotein, HDL cholesterol, arterial intima, atherosclerosis, lipoprotein retention, aortic arch, lipoprotein particle size, serum lipoproteins
MeSH terms: Albumins, Animals, Arteries, Female, Hyperlipidemias, Lipoproteins, Lipoproteins, LDL, Lipoproteins, VLDL, Male, Microscopy, Electron, Particle Size, Rabbits, Tunica Intima, Tunica Media, Lipoproteins, IDL

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo: Molecular Size as a Determinant of Fractional Loss From the Intima–Inner Media

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks